Mark Wilterding
Chief Financial Officer · RxSight, Inc.
IndividualSelling only
- 2026
- Sep 10, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark Wilterding files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ronald M. Md Kurtz - $35K in RXST purchases and sales in the last 12 months
- Ilya Goldshleger - $14K in RXST purchases and sales in the last 12 months
- Eric Weinberg - $14K in RXST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark Wilterding?
Mark Wilterding is a corporate insider, tracked as Chief Financial Officer of RxSight, Inc. (RXST). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark Wilterding submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Mark Wilterding been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($54K) across all tracked filings.
